Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
IPCA Laboratories, a leading pharmaceutical company headquartered in India, specializes in the development and manufacturing of high-quality generics and active pharmaceutical ingredients (APIs). The company offers a broad spectrum of therapeutic solutions, serving global markets with innovative and affordable medicines.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
IPCA Laboratories is scheduled to report its next quarterly earnings on 11/06/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
IPCA Laboratories last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at 15.84 INR.
IPCA Laboratories has beaten analyst EPS estimates in 3 of its last 3 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.